Eprozinol

Eprozinol
Names
Preferred IUPAC name
3-[4-(2-Methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-1-ol
Identifiers
CAS Number
  • 32665-36-4 checkY
3D model (JSmol)
  • Interactive image
ChEMBL
  • ChEMBL2107691 ☒N
ChemSpider
  • 109268 ☒N
ECHA InfoCard 100.046.482 Edit this at Wikidata
KEGG
  • D07379 checkY
PubChem CID
  • 122553
UNII
  • IJ21AK8IVJ checkY
CompTox Dashboard (EPA)
  • DTXSID10865642 Edit this at Wikidata
InChI
  • InChI=1S/C22H30N2O2/c1-26-22(20-10-6-3-7-11-20)18-24-16-14-23(15-17-24)13-12-21(25)19-8-4-2-5-9-19/h2-11,21-22,25H,12-18H2,1H3 ☒N
    Key: QSRHLIUOSXVKTG-UHFFFAOYSA-N ☒N
  • COC(CN1CCN(CC1)CCC(C2=CC=CC=C2)O)C3=CC=CC=C3
Properties
Chemical formula
 C22H30N2O2
Molar mass 354.4858
Pharmacology
R03DX02 (WHO)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Infobox references
Chemical compound

Eprozinol is a drug for obstructive airway disease.[1][2]

References

  1. ^ Nicrosini, F.; Carpinella, G. (1978). "Eprozinol treatment of chronic bronchitis with dyspnea and cough". Broncho-pneumologie. 28 (4): 322–327. PMID 756799.
  2. ^ Labrid, C.; Duchene-Marullaz, P.; Rispat, G. (1981). "Mechanisms of anti-bronchoconstrictive effects of eprozinol. II. In vivo studies on the guinea pig". Pharmacology. 23 (1): 48–55. doi:10.1159/000137526. PMID 7312935.
  • v
  • t
  • e
Drugs for obstructive airway diseases: asthma/COPD (R03)
Adrenergics, inhalants
Short-acting β2 agonists
Long-acting β2 agonists
Ultra-long-acting β2 agonists
Other
GlucocorticoidsAnticholinergics/
muscarinic antagonistMast cell stabilizersXanthinesEicosanoid inhibition
Leukotriene antagonists
Arachidonate 5-lipoxygenase inhibitors
Thromboxane receptor antagonists
Non-xanthine PDE4 inhibitors
Others/unknownCombination products


Stub icon

This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e